Table 1.
Receptor | Localization | Common agonist | Common antagonist | Convulsive seizures | Neurotransmitter release | Reference |
---|---|---|---|---|---|---|
mGlu1, mGlu5 | Postsynaptic neurons, presynaptic terminals, glial cells | Nonselective (1S, 3R)-ACPD, (R,S)-CHPG, (S)-3,5-dihydrox-yphenylglycine, L-quisqualic acid | (S)–MCPG, (T) AIDA, (U) (S)-4CPG | Proconvulsive | Enhancement | Thomsen and Dalby, 1998; Tang et al., 2009; Gregory and Goudet, 2021 |
mGlu2, mGlu3 | Presynaptic membranes, postsynaptic membranes, glial cells | Nonselective (1S, 3R)-ACPD, DCG-IV, pomaglumetad (S)-4-carboxy-3-hydroxyphenylglycine | CPPG, (S)–MCPG, (T) L-serine-O-phosphate | Anticonvulsant | Reduction | Folbergrova et al., 2001; Alexander and Godwin, 2006; Gregory and Goudet, 2021 |
mGlu4, mGlu6, mGlu7, mGlu8 | Presynaptic membranes, presynaptic membranes, glutamatergic and GABAergic neurons, glial cells | ACPT-1, cinnabarinic acid, L-serine-O-phosphate’ (RS)-PPG, cyclobutylene AP5 | CPPG, (S)–MCPG, (T) MSOP | Mixed responses | Reduction | Thomsen and Dalby, 1998; Folbergrova et al., 2001; Gregory and Goudet, 2021 |
(R, S)-PPG: (R,S)-4-phosphonophenylglycine; 1S,3R-ACPD: 1S,3R-1-aminocyclopentane-1,3-dicarboxylic acid; ACPT-1: (1S,3R,4S)-1-aminocyclopentane-1,2,4-tricarboxylic acid; AIDA: 1-aminoindan-1,5-dicarboxylic acid; CHPG: (R,S)-2-chloro-5-hydroxyphenylglycine; CPPG: α-cyclopropyl-4-phosphonophenylglycine; Cyclobutylene AP5: (RS)-1-amino-3-(phosphonomethylene) cyclobutene-carboxylic acid; DCG IV: (2S,2’R,3’R)-2-(2’,3’-dicarboxycyclopropyl)glycine; MCPG: α-methyl-4-carboxyphenylglycine; mGluR: metabotropic glutamate receptor; M-SOP: α-methylserine-O-phosphate; S-3,4-DCPG: (S)-3,4-dicarboxyphenylglycine. (S), (U), (T) represent the different relative configurations of the chiral centres.